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Abstract Dientamoeba fragilis is a protozoan with a debated
role in gastrointestinal (GI) disease. Although correlated to GI
symptoms, no virulence factors have been described. In this
study, we evaluated the cause of GI symptoms in children at
two schools, with children aged 1 to 10 years, in the county of
Jönköping, Sweden. D. fragilis infection correlated to GI
symptoms in children and Enterobius vermicularis correlated
to D. fragilis infection.
Introduction
Dientamoeba fragilis is a protozoan suspected of causing gas-
trointestinal (GI) symptoms [1, 2], although its aetiological
role in GI disease is controversial [3–6]. The reported preva-
lence ofD. fragilis in individuals suffering fromGI symptoms
varies from 1 to 70% [4, 7, 8]. No difference in the prevalence
of D. fragilis has been found in patients suffering from irrita-
ble bowel syndrome [6] or children with chronic abdominal
pain [9] compared to individuals without symptoms. The life
cycle of D. fragilis and its mode of transmission are not fully
understood and a faecal–oral transmission seems unlikely
[10]. It has been hypothesised that Enterobius vermicularis
may serve as a vector for D. fragilis and, recently, D. fragilis
DNA has been detected in E. vermicularis eggs [11].
Traditionally, parasites are detected by microscopy of con-
centrated unfixed or fixed faecal samples [12]. However, as
trophozoites ofD. fragilis rapidly degenerate outside the host,
probably due to the lack of a cyst form [2, 13], a prompt
fixation of faecal samples is essential. Also, concentration
should be omitted and stained permanent smears or direct
wet mounts should be used for the detection of D. fragilis
trophozoites [12, 14].
Since the introduction of polymerase chain reaction (PCR),
the detection ofD. fragilis has increased [4, 7, 8]. In this study,
we use a multiplex PCR assay modified for sodium acetic acid
formaldehyde (SAF)-fixated samples to allow comparison
with microscopy results on the same samples.
In March 2012, a school nurse alerted the Department for
Control of Communicable Diseases in Jönköping County,
Sweden, since many children at the school complained of GI
symptoms.
We investigated possible infectious causes of GI symptoms
in these children. In addition, a multiplex PCR for parasites on
SAF-fixated faecal samples was established.
Materials and methods
Study populations and GI symptoms
Faecal samples (n=299) were obtained from school children
(n=146; 1 to 10 years old) and members of the staff (n=16) at
the school where children complained of GI symptoms
(school A). Sticky tape tests for E. vermicularis detection were
obtained from 47 children. Faecal samples from parents (n=
123) and siblings (n=14) were also included. For comparison,
faecal samples (n=89) and sticky tape tests (n=33) were ob-
tained from children aged 1 to 10 years from another school
(school B) in the county. In addition, the results from clinical
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samples (n=7684) submitted for parasitological investigation
to the Clinical Microbiology Laboratory, Jönköping, Sweden
in 2012 were included.
Parents to children answered a questionnaire for the ep-
idemiological investigation of GI diseases. Information on
GI symptoms [abdominal pain (recurring and/or lasting
more than 2 weeks), diarrhoea, nausea or constipation]
within 3 months prior to testing was registered.
Information regarding GI symptoms was not available for
the clinical samples.
Microscopy for parasites
Faecal samples were immediately fixed in SAF. Samples were
then homogenised and sifted, and half of the faecal suspension
was concentrated by ethyl acetate treatment. Microscopy
(100× and 400×) was done on concentrated material, on direct
wet mounts from unconcentrated material and on sticky tape
tests.
Multiplex real-time PCR for parasites
An SAF-fixated faecal solution (1000 μL) was centrifuged
at 10,000 × g for 1 min. Pellets were then washed with
phosphate-buffered saline (PBS) pH 7.4 for 1 min, follow-
ed by another centrifugation step. Pellets were suspended
in a mixture of 280 μl AL lysis buffer and 20 μL proteinase
K (Qiagen, Hilden, Germany), and incubated at 56 °C for
1 h with gentle agitation. Suspensions were then frozen at
−196 °C for 30 min and, finally, heated at 98 °C for
15 min. DNA extraction was done with a MagAttract
DNA Mini M48 kit (Qiagen) in an M48 instrument
(Qiagen). Real-time PCR for parasite detection was done
with the LightCycler 480 II instrument (Roche Diagnostics
GmbH, Mannheim, Germany), according to Verweij et al.
[7, 15], modified by the inclusion of Entamoeba dispar
[16].
Analysis of faecal samples
Samples from 30 children aged 6 to 8 years in school Awere
also analysed for the presence of GI pathogens, including
standard faecal culture, PCR for norovirus, sapovirus [17]
and enterohaemorrhagic Escherichia coli (EHEC) [18], and
antigen detection for rotavirus and adenovirus (Coris
BioConcept Combi-Strip, Gembloux, Belgium). All samples
from schools A and B were analysed for parasites by multi-
plex PCR and microscopy, including direct wet mounts for
trophozoite detection. Clinical samples were exclusively
analysed by microscopy.
Results
GI bacterial and viral pathogens
In none of the 30 samples were Campylobacter spp.,
Salmonella spp., Shigella spp., Yersinia spp., EHEC, rotavi-
rus, adenovirus or norovirus detected.
Parasites detected by microscopy
D. fragilis trophozoites were detected in direct wet mounts of
unconcentrated faecal samples in 60, 60 and 15 % of samples
from school A, school B and in clinical samples, respectively
(Table 1). E. vermicularis eggs were detected in 13 out of 47
(28 %) sticky tape samples from school A and in 8 out of 33
(24 %) from school B. The prevalence ofD. fragiliswas 95%
(20 out of 21) in those positive for E. vermicularis and 69 %
(41 out of 59) in those negative for E. vermicularis (p=0.03).
In concentrated faecal samples, Blastocystis hominis was
found in nine children and 30 adults at school A and in four
children from school B; no other pathogenic parasites or hel-
minths were found. In the clinical samples, 30 E. histolytica/
dispar, 90Giardia intestinalis, 29 Cryptosporidium spp., 55
helminth eggs or larvae, and 787 B. hominis were found.
Prevalence of D. fragilis and recovery by PCR
The age-stratified prevalence of D. fragilis detected with mi-
croscopy is shown in Table 1. There was no difference in
D. fragilis prevalence in samples from school A and school
B. The prevalence in samples from the age group 6–10 years
was higher at schools A and B and in clinical samples, com-
pared to all the other age groups studied (p<0.000 to p=0.02).
The prevalence of D. fragilis in individuals over 15 years old
in school A (parents, staff and siblings) was higher compared
to clinical samples (p<0.0000).
All samples positive for D. fragilis by microscopy were
also positive by PCR. Out of the total of 388 samples,
D. fragilis was detected in 233 samples by microscopy and
in 281 samples by PCR, respectively. This correlates to an
increased recovery of 20 % (p<0.000).
Relation between GI symptoms and D. fragilis infection
In school A, 102 questionnaires out of 155 were answered and
in 76 children (75 %), one or more of the symptoms were
documented. In school B, 60 out of 89 questionnaires were
answered and in 32 children (53 %), one or more symptoms
were documented. The prevalence ofD. fragiliswas higher in
those having GI symptoms compared to children without
symptoms (Table 2).
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Discussion
In this study, we found that D. fragilis infection in children
under the age of 11 years coincided with GI symptoms. This
was not found in individuals over 10 years of age (data not
shown). These findings are in agreement with previous studies
on children [5] and adults [6], and suggest a role ofD. fragilis in
GI disease in children. The prevalence ofD. fragiliswas higher
in the two schools studied compared to clinical samples.
Interestingly, the prevalence in adults at school A was equally
high as that in the children, whereas in clinical samples, the
prevalence was less than 10 %. This is in agreement with
previous findings of a high prevalence of D. fragilis in adults
with close contact to children [4].
A drawback of this study was that GI symptoms were eval-
uated by reviewing questionnaires answered by parents and
with no gradient scale to describe the severity of the symp-
toms. However, at school A, the symptoms were severe
enough to alert the school nurse to contact the Department
for Control of Communicable Diseases.
We found a higher prevalence of D. fragilis in children
simultaneously infected with E. vermicularis compared to
children with no E. vermicularis eggs detected. The results
confirm previous studies based on the analysis of sticky tape
test for the detection of E. vermicularis [19] but contradicts
results from studies based on the analysis of faecal samples for
E. vermicularis detection [20]. Our results indicate a role for
E. vermicularis in the transmission of D. fragilis. Recently,
D. fragilis DNAwas detected in E. vermicularis eggs [11, 21]
and in a study on metronidazole treatment ofD. fragilis infec-
tion, E. vermicularis co-infection increased the risk of post-
treatment D. fragilis infection [22]. Our finding of an equally
high prevalence ofD. fragilis in adults in contact with infected
children raises the question regarding the routes of transmis-
sion to adults. Recently, a cyst form of D. fragilis has been
detected in faeces from humans, but a possible faecal–oral
transmission has not been documented [23, 24].
In this study, we found that a multiplex PCR, adapted to
SAF-fixated faecal samples, increased the detection of
D. fragilis by 20 % compared to microscopy.
In conclusion, our findings add to the opinion that
D. fragilis might have an aetiological role in GI symptoms
in children, and that E. vermicularis has a possible role in
the transmission of D. fragilis.
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